Alphatec Holdings Inc. logo

Alphatec Holdings Inc. (L1Z1)

Market Closed
8 Aug, 20:00
XBER XBER
12. 54
-0.14
-1.1%
- Market Cap
- P/E Ratio
0% Div Yield
0 Volume
-1.44 Eps
12.68
Previous Close
Day Range
12.54 12.54
Year Range
4.48 12.96
Want to track L1Z1 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 79 days

Summary

L1Z1 closed yesterday lower at €12.54, a decrease of 1.1% from Thursday's close, completing a monthly increase of 35.1% or €3.26. Over the past 12 months, L1Z1 stock gained 43.26%.
L1Z1 is not paying dividends to its shareholders.
The last earnings report, released on Jul 31, 2025, exceeded the consensus estimates by 0.06%. On average, the company has surpassed earnings expectations by 0.07%, based on the last three reports. The next scheduled earnings report is due on Oct 28, 2025.
Alphatec Holdings Inc. has completed 2 stock splits, with the recent split occurring on Aug 25, 2016.
The company's stock is traded on 8 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).

L1Z1 Chart

Chart

Chart with 60 data points.
The chart has 1 X axis displaying categories.
The chart has 2 Y axes displaying values, and values.
End of interactive chart.
These 3 health tech stocks spiked 37% in a day; Time to buy?

These 3 health tech stocks spiked 37% in a day; Time to buy?

While the broader stock market suffered steep losses on Friday amid trade policy shifts and troubling economic data, select health technology equities stood out.

Finbold | 5 days ago
Alphatec Holdings, Inc. (ATEC) Q2 2025 Earnings Call Transcript

Alphatec Holdings, Inc. (ATEC) Q2 2025 Earnings Call Transcript

Alphatec Holdings, Inc. (NASDAQ:ATEC ) Q2 2025 Earnings Conference Call July 31, 2025 4:30 PM ET Company Participants J. Todd Koning - Executive VP & CFO Patrick S.

Seekingalpha | 1 week ago
Alphatec (ATEC) Beats Q2 Earnings and Revenue Estimates

Alphatec (ATEC) Beats Q2 Earnings and Revenue Estimates

Alphatec (ATEC) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.06 per share. This compares to a loss of $0.29 per share a year ago.

Zacks | 1 week ago

Alphatec Holdings Inc. Dividends

L1Z1 is not paying dividends to its shareholders.

Alphatec Holdings Inc. Earnings

30 Oct 2025 (In 2 months) Date
-
Cons. EPS
-
EPS
29 Oct 2025 (In 2 months) Date
-
Cons. EPS
-
EPS
28 Oct 2025 (In 2 months) Date
-
Cons. EPS
-
EPS
31 Jul 2025 Date
-
Cons. EPS
-
EPS
30 Jul 2025 Date
-
Cons. EPS
-
EPS
L1Z1 is not paying dividends to its shareholders.
30 Oct 2025 (In 2 months) Date
-
Cons. EPS
-
EPS
29 Oct 2025 (In 2 months) Date
-
Cons. EPS
-
EPS
28 Oct 2025 (In 2 months) Date
-
Cons. EPS
-
EPS
31 Jul 2025 Date
-
Cons. EPS
-
EPS
30 Jul 2025 Date
-
Cons. EPS
-
EPS

Alphatec Holdings Inc. (L1Z1) FAQ

What is the stock price today?

The current price is €12.54.

On which exchange is it traded?

Alphatec Holdings Inc. is listed on NASDAQ (NGS).

What is its stock symbol?

The ticker symbol is L1Z1.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, no market cap data is available.

When is the next earnings date?

The next earnings report will release on Oct 28, 2025.

Has Alphatec Holdings Inc. ever had a stock split?

Alphatec Holdings Inc. had 2 splits and the recent split was on Aug 25, 2016.

Alphatec Holdings Inc. Profile

Medical - Devices Industry
Healthcare Sector
Patrick S. Miles CEO
XBER Exchange
US02081G2012 ISIN
US Country
867 Employees
- Last Dividend
25 Aug 2016 Last Split
2 Jun 2006 IPO Date

Overview

Alphatec Holdings, Inc., founded in 1990 and headquartered in Carlsbad, California, is a distinguished medical technology company focused on the design, development, and commercialization of innovative technologies for the surgical treatment of spinal disorders. Operating both in the United States and internationally, Alphatec manufactures and supplies its revolutionary products through a combination of third-party suppliers, independent sales agents, and direct sales representatives. The company's commitment to advancing spinal surgery technologies has positioned it as a leader in its field, offering a wide range of solutions aimed at improving patient outcomes.

Products and Services

  • Alpha InformatiX Product Platform – A comprehensive suite of solutions that includes:
    • EOS imaging system: Offers full-body imaging for enhanced diagnostic capabilities.
    • VEA alignment mobile application: Leverages EOS technology, enabling quick quantification of alignment parameters on mobile devices.
    • SafeOp Neural InformatiX System: Automates electromyographic and somatosensory evoked potential monitoring for increased safety.
    • Valence: Integrates navigation and robotics into spine procedures, optimizing surgical outcomes.
  • Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems – Designed to improve accessibility and patient positioning during surgery.
  • Spinal Implants and Fixation Systems – Includes:
    • NanoTec surface modifications: Enhance implant integration and stability.
    • Calibrate PSX and Invictus: Offer advanced spinal fixation solutions.
    • Standalone implants: Provide options for height restoration and stabilization.
  • Biological Solutions – A diverse portfolio of biologics designed to support spinal surgery and healing, comprising:
    • 3D ProFuse Osteoconductive Bioscaffold: Facilitates ease of handling and improved endplate contact.
    • AlphaGRAFT Demineralized Bone Matrix (DBM): Utilizes demineralized human tissues for bone grafting.
    • AlphaGRAFT DBM Fibers: Offers demineralized fibers for versatile use in bone grafts.
    • AlphaGRAFT Cellular Bone Matrix (CBM): A growth factor-enriched cellular bone matrix available in various forms for different surgical needs.
    • BioCORE Moldable Bioactive Graft: A moldable, synthetic mineral-collagen composite matrix designed to fit bone defects.
    • Amnioshield Amniotic Tissue Barrier: An allograft used for spinal surgical barrier applications.

Contact Information

Address: 1950 Camino Vida Roble
Phone: 760 431 9286